Assembly of the heterotrimeric influenza polymerase complex from the individual subunits 24 PB1, PA and PB2 is a prerequisite for viral replication. The conserved protein-protein 25 interaction sites have been suggested as potential drug targets. To characterize the PB1-PB2 26 interface, we fused the PB1-binding domain of PB2 to GFP (PB2 1-37 -GFP) and determined its 27 competitive inhibitory effect on the polymerase activity of influenza A virus strains. Co-28 expression of PB2 1-37 -GFP in a polymerase reconstitution system led to substantial inhibition 29 
7
PB2 1-37 -Biotin was obtained from Pepscan Presto, the Netherlands. PB1 1-25 scrambled -Biotin was 145 used as a control peptide and was previously described (45) . 146
Immunoprecipitation experiments 147
293T cells were transfected with the indicated plasmids in 6-well plates using Lipofectamine 148 (Invitrogen). Cells were incubated 24 h post transfection with lysis buffer (20 mM Tris pH 149 7.5, 100 mM NaCl, 0.5 mM EDTA, 0.5% NP-40, 1% Protease inhibitor Mix G, (Serva, 150 Heidelberg, Germany), 1 mM DTT) for 15 min on ice. After centrifugation by 13000 rpm at 151 4°C the supernatant was incubated with anti HA-or Flag-specific antibodies coupled to 152 agarose beads (Sigma) for 1 h at 4°C. After three washes with 1 ml of washing buffer (lysis 153 buffer without protease inhibitor mix), bound material was eluted under denaturing conditions 154 and separated on SDS-PAGE gels and transferred to PVDF membranes. When indicated, 155 mixing of cell extract prior immunoprecipitation was performed on ice for 1 h. Viral 156 polymerase subunits, GFP fusion proteins or actin (cell extract only) were detected with 157 antibodies directed against the HA-(Covance, Berkeley, California), Flag-(Sigma-Aldrich), 158 GFP-tag (Santa Cruz Biotechnology), PB1 (kindly provided by Paul Digard) or actin (Sigma-159 Aldrich). 160
161
ELISA to determine binding of PB1 or PB1/PA dimers to PB2 
in vitro 162
Streptavidin-coated microwell plates were incubated with saturating concentrations of 163 biotinylated PB2 1-37 peptide, washed and subsequently incubated at room temperature with 164 HA-tagged PB1. To obtain PB1-HA or PB1/PA-HA dimers, 293T cells were seeded into 94 165 mm-dishes, transfected with the respective plasmids and treated with lysis buffer 24 h post 166 transfection as previously described (45). After washing the microwell plates, the wells were 167 incubated with a HA-specific primary antibody (Covance, MMS-101R), followed by three 168 washes and incubation with a peroxidase-coupled secondary antibody (Jackson Immuno 169 on January 20, 2018 by guest http://jvi.asm.org/ Downloaded from 8 Research, Newmarket, UK). After the final wash step, ABTS-substrate (Sigma, ready-to-use 170 solution) was added and the optical density was determined at 405 nm. 171
172

Results
173
PB2 1-37 -GFP specifically binds to PB1 and inhibits the polymerase of WSN. 174
To address the question whether the PB1-PB2 interaction site can be verified as an antiviral 175 target experimentally, we co-expressed the highly conserved PB1-binding domain of PB2 176
derived from an influenza A virus PB2 consensus sequence (Fig.1 A) as a GFP fusion 177 construct (PB2 1-37 -GFP) in a WSN polymerase activity reconstitution assay. As a control, PX-178 GFP, which harbors the X-binding domain of the P protein of Borna disease virus (16), was 179 set to 100%. As shown in Fig. 1B and C, the WSN polymerase can be inhibited by 180 PB2 1-37 -GFP to about 20% compared to the control in a concentration dependent manner. The 181 degree of inhibition was similar to the previously described inhibition by PB1 1-25 -GFP (Fig.  182 1B) (16, 45) . Since the PB1-binding domain of PB2 between influenza A and B viruses show 183 a virus-type specific conservation and little sequence identity in the first 37 amino acids (Fig. 184 1A), we speculated that PB2 1-37 -GFP might fail to inhibit the polymerase activity of an 185 influenza B virus strain. Indeed, the polymerase activity of B/Yamagata/73 was not affected 186 by PB2 1-37 -GFP (Fig. 1D) . Consistent with this observation, PB2 1-37 -GFP failed to bind to 187 PB1 of B/Yamagata/73 (Fig. 1E ). Next we wanted to map the minimal inhibitory domain of 188 PB2 1-37 . Since PB2 1-37 folds into 3 discrete α-helices (42), expression plasmids were 189 generated coding for truncated versions of PB2 1-37 -GFP, designated PB2 1-23 -GFP and PB2 1-12 -190 GFP, containing either α 1 and α 2 or only α 1 -helix. As shown in Fig. 1F both truncated  191 versions of PB2 1-37 -GFP maintained their inhibitory effect on the WSN polymerase, albeit to 192 a slightly weaker extent. This degree of inhibition correlated with binding of the GFP-fusion 193 constructs to PB1-HA in a co-immunoprecipitation assay (Fig. 1G) (Fig. 2A) . However, only substitution of leucine at position 7 and methionine 199 at position 11 reduced the inhibitory effect on the polymerase (Fig. 2B) , correlating with 200 reduced binding in a co-immunoprecipitation (Fig. 2C and D) . In contrast, substitution from 201 arginine to alanine at position 8 rendered the PB2 1-37 -GFP more active (Fig. 2B) . To address 202 the relevance of these mutations in the context of the PB2 full length protein, the mutations 203 L7A (PB2 L7A ), R8A (PB2 R8A ) or M11A (PB2 M11A ) were introduced into PB2 WSN and tested in 204 the polymerase reconstitution assay. As shown in Fig. 2E , these mutant proteins supported the 205 polymerase activity (Fig. 2E) . 206
A panel of influenza A virus polymerases show varying degrees of sensitivity to PB2 1-37 -GFP. 207
The high amino acid sequence conservation among influenza A viruses at the PB1-PB2 208 binding site strongly suggested that all influenza A virus polymerases should be sensitive to 209 inhibition by PB2 1-37 -GFP. To verify this hypothesis we tested a panel of influenza A virus 210 polymerases from various strains including A/SC35M (H7N7) (SC35M), A/PR/8/34 (H1N1) 211 for inhibition by PB2 1-37 -GFP. To our surprise, only the WSN polymerase activity was 213 reduced to about 20% of the PX-GFP control (Fig. 3A) . In contrast the polymerase of SC35M 214 and HH4 even displayed a slight increase in activity in the presence of PB2 1-37 -GFP (Fig. 3B  215 10 of PB2 1-37 -GFP were compared (Fig. 3F ). This revealed lowest polymerase activity for the 220 sensitive WSN polymerase. However, one of the most active polymerases, namely KAN1 221 (Fig. 3F) , is partially inhibited by PB2 1-37 -GFP (Fig. 3C) , suggesting that the sensitivity to 222 PB2 1-37 -GFP is independent of the polymerase activity. 223
Resistance of the SC35M polymerase is independent of the polymerase activity and not 224 affected by a WSN-specific amino acid residue within PB2 To further investigate why only the WSN polymerase could be substantially inhibited by 226 PB2 1-37 -GFP, despite high sequence-conservation of the target structure, we proceeded to 227 compare this sensitive polymerase to the highly resistant polymerase of SC35M. We first 228
wanted to rule out that the inhibitory effect of PB2 1-37 -GFP is caused by differences in 229 polymerase activity. We therefore compared the polymerase activity of WSN and SC35M in 230 presence of the control PX-GFP or PB2 1-37 -GFP at different time points post transfection (Fig. 231 4A and B) . If the high polymerase activity of SC35M would simply overrun the inhibitory 232 effect of PB2 1-37 -GFP we would expect to see inhibition of SC35M polymerase at early time 233 points post transfection. However, in contrast to the polymerase of WSN (Fig. 4A) , the 234 SC35M polymerase is not inhibited by PB2 1-37 -GFP at any of the measured time-points (Fig. 235 4B) , indicating that the strain-dependent difference in polymerase activity is most-likely not 236 responsible for the resistance to PB2 1-37 -GFP. 237
A striking difference between WSN and SC35M is the amino acid substitution N to D at 238 position 9 of PB2 (Fig. 4C) , which might cause the differences in the susceptibility to 239 PB2 1-37 -GFP. We therefore introduced this mutation into PB2 1-37 -GFP and tested for 240 inhibition of the polymerase activity of those two influenza A virus strains. However, whereas 241 the polymerase of WSN was inhibited by PB2 1-37 N9D-GFP (Fig. 4D) , the SC35M polymerase 242 remained resistant (Fig. 4E) GFP. In contrast, the activity of the SC35M polymerase increased to ca. 150% in the presence 248 of PB1 678-757 -GFP (Fig. 4G) , consistent with an increase in polymerase activity of SC35M in 249 the presence of PB2 1-37 -GFP (Fig. 3B ). The R8A mutation in PB2 1-37 -GFP (PB2 1-37 R8A-GFP) 250 which resulted in an increased inhibition of the WSN polymerase activity (Fig. 2B ), does not 251 potentiate the activity against the resistant SC35M polymerase (Fig. 4H ). In conclusion, 252 resistance of SC35M to PB2 1-37 -GFP did not depend on polymerases activity, a strain-specific 253 amino acid substitution in PB2 nor on the interaction domain (PB1-or PB2-binding domain) 254
used for inhibition. 255
Resistance to PB2 1-37 -GFP is mediated by either PB1 SC35M or PA SC35M . 256
In order to identify the viral proteins determining the resistance to PB2 1-37 -GFP, we 257 exchanged all viral ribonucleoprotein (vRNP) components (NP, PB1, PB2 and PA) of the 258 sensitive WSN polymerase by their SC35M counterparts and determined the polymerase 259 activity in the presence of PB2 1-37 -GFP. With the exception of PB2 SC35M , which reduced the 260 polymerase activity to background levels, reconstitution of the WSN polymerase with 261 NP SC35M or PA SC35M resulted in similar polymerase activity as observed with the WSN 262 polymerase, whereas an even increased activity was determined with PB1 SC35M (Fig. 5A) . 263
Although PB2 SC35M rendered the WSM polymerase inactive, the trimeric polymerase complex 264 was formed with PA WSN and PB1 WSN (Fig. 5B ). However, PB2 WSN supported the polymerase 265 activity of SC35M (Fig. 5C ). The incompatibility of WSN and SC35M PB2 might be either 266 caused by impaired polymerase assembly or the presence of PB2 627E in SC35M, which 267 drastically reduces polymerase activity when introduced into PB2 WSN (25). Since we could 268 rule out the assembly defect and PB2 WSN is functional in the SC35M minireplicon we assume 269 on January 20, 2018 by guest http://jvi.asm.org/ Downloaded from 12 that the the avian signature glutamic acid 627 in PB2 SC35M causes the observed de-270 functionality. Consequently, we could not assess the role of PB2 SC35M in the resistant 271 phenotype. However, exchange of the remaining RNP components yielded insights into the 272 resistant phenotype of SC35M. Importantly, while NP SC35M did not alter the sensitive 273 phenotype of the WSN polymerase in the presence of PB2 1-37 -GFP (Fig. 5D) , exchange of the 274 polymerase subunits PB1 (Fig. 5E ) and PA (Fig. 5F ) by their SC35M counterparts turned the 275 polymerase resistant to inhibition by PB2 1-37 -GFP. Intriguingly, PA SC35M conferred resistance 276 of the WSN polymerase to PB2 1-37 -GFP, although no direct interaction with PA was observed 277 (Fig. 6H) . 278
Resistance to PB2 1-37 -GFP correlates with impaired PB1/PA dimer binding. 279
We speculated that the actual target structure of PB2 1-37 -GFP should be the PB1/PA dimer 280 instead of the PB1 monomer, since it was shown that preformed PB1/PA dimers 281 preferentially associate with PB2 (6). Furthermore, the observation that PA SC35M confers 282 resistance to PB2 1-37 -GFP (Fig. 5F ) suggests that the PA/PB1 dimer and not PB1 alone is 283 decisive for sensitivity or resistance. We therefore hypothesized that resistance to 284 PB2 1-37 -GFP is mediated by a failure to bind to the PB1 SC35M /PA SC35M dimer. In order to study 285 the interaction between PB2 1-37 with either PB1 or the PB1/PA dimer in a minimal setting, we 286 established an ELISA-based binding assay. In this assay, biotinylated PB2 1-37 was bound to 287 neutravidin-coated 96 well plates and probed for binding of HA-tagged PB1 or PB1/PA-HA 288 expressed from HEK293T cells. The amount of bound PB1-HA or PB1/PA-HA was 289 determined using antibodies specifically recognizing the HA tag. As shown in Fig. 6A , the 290 HA-tagged PB1 of both WSN and SC35M, designated PB1 WSN -HA and PB1 SC35M -HA, bind 291 to the immobilized PB2 1-37 peptides in a dose dependent manner. PA-HA, which was used as 292 a specificity control, did not bind to PB2 1-37 (data not shown HA-specific antibodies reflect specific binding of PB1/PA-HA dimers, but not PB1 296 monomers. As shown in Fig. 6B , PB1 WSN /PA WSN -HA dimers efficiently associate with PB2 1-297 37 in a dose dependent manner. Furthermore, binding of these dimers to PB2 1-37 was slightly 298 more efficient than that of the PB1 WSN -HA monomer (Fig. 6A ) at comparable expression 299 levels (Fig. 6D) . Thus, the PB1/PA dimer seems to be the bona fide target structure for PB2 1-300 37 -GFP. In contrast, PB1 SC35M /PA SC35M -HA failed to bind to PB2 1-37 efficiently (Fig. 6B) . 301
Since both PB1 SC35M and PA SC35M mediated resistance to PB2 1-37 -GFP in the WSN 302 ribonucleoprotein reconstitution assay, we expected that PB1 WSN /PA SC35M -HA and 303 PB1 SC35M /PA WSN -HA dimers should also fail to bind to PB2 1-37 because they led to resistance 304 of the polymerase in the subunit swap experiment (Fig. 5 E and F) . Indeed, these mixed 305 dimers showed reduced binding to PB2 1-37 (Fig. 6C) . Since all PB1/PA combinations showed 306 similar expression levels as analyzed by Western blot (Fig. 6E ) and since PB1 WSN /PA SC35M -307 HA and PB1 SC35M /PA WSN -HA efficiently associated into dimers as judged by co-308 immunoprecipitation studies (Fig. 6F) we concluded that the resistant phenotype of either the 309 SC35M polymerase or a WSN polymerase harboring PB1 SC35M or PA SC35M is caused by 310 impaired binding to PB2 1-37 -GFP. To confirm this finding in a cellular system we tested for 311 PB2 1-37 -GFP binding to the indicated PB1/PA-HA dimers in co-immunoprecipitation 312 experiments ( Fig. 6G and H) . These studies confirmed that PB1 WSN -HA as well as 313 PB1 WSN /PA WSN -HA efficiently form complexes with PB2 1-37 -GFP (Fig. 6G) . However, 314 whereas PB1 SC35M -HA bound to PB2 1-37 -GFP, we observed a reduced binding of PB2 1-37 -GFP 315 by the PB1 SC35M /PA SC35M -HA dimer (Fig. 6H) . We repeatedly observed decreased and 316 varying levels of PB2 1-37 GFP in the cell extract used for immunoprecipitation. To accurately 317 quantify the binding efficiencies, we expressed PB1-HA, PB1/PA-HA and PB2 1-37 GFP 318
individually and used those cell extracts for a pull-down assay. Consistent with the results 319 observed after simultaneous expression of all components (Fig. 6G and H) , binding of PB2 1-320 on January 20, 2018 by guest http://jvi.asm.org/ Downloaded from 14 37 GFP was less efficient to the PA/PB1 dimer of SC35M than of WSN (Fig. 6I and J) . Based 321 on these results we hypothesized that PB1 SC35M /PA SC35M dimer formation results in a 322 conformational change of PB1 SC35M thereby shielding the C-terminal PB1 domain from 323 interaction with PB2 1-37 -GFP. Interestingly, PA SC35M was sufficient to confer resistance to the 324 WSN polymerase (Fig. 5F ). To address the question which domain of PA SC35M was 325 responsible for this "closed" dimer conformation, defined here as not accessible for 326 PB2 1-37 -GFP, we designed PA WSN/SC35M chimeras and tested them for inhibition by 327 (Fig. 7A) . These PA chimera supported the WSN polymerase 333 activity, although to a different extent as depicted in Fig. 7B . However, PA 1-277 SC35M ,278-334 716 WSN was still able to confer resistance in the WSN polymerase reconstitution assay (Fig.  335   7C ), albeit to a slightly decreased extent compared to PA SC35M (Fig. 5F ). In contrast, the 336 polymerase of WSN with PA 1-277 WSN ,278-716 SC35M was sensitive to inhibition by 337 PB2 1-37 -GFP (Fig. 7D) . Consistent with the resistant phenotype mediated by PA 1-338 277 SC35M ,278-716 WSN, we observed reduced binding of PB2 1-37 -GFP to PB1 WSN /PA 1-339 277 SC35M ,278-716 WSN dimers in co-immunoprecipitation experiments using either extracts of 340 cells transiently transfected with the polymerase subunits and PB2 1-37 -GFP (Fig. 7E) or after 341 combining cell extracts harboring either PB2 1-37 -GFP or the PA/PB1 dimers (Fig. 7F and G) . 342
In summary, these results mapped the resistance to PB2 1-37 -GFP to the N-terminal domain of 343 the PA protein. containing the first α-helix of PB2 would not fold into its three dimensional structure and 362 thereby fail to bind to PB1 (42), the PB2 1-12 -GFP fusion construct remained its inhibitory 363 activity and its capacity to bind to PB1, presumably by stabilization of the folding by the 364 fusion to GFP. Thus, only considering the inhibition of the WSN polymerase, this short 12aa 365 sequence would be a valuable starting point for the development of antiviral peptides or 366 peptidomimetics, which would in this case be favored over small molecule inhibitors due to 367 the flat and extended fold of the targeted interaction site (42). However, despite high sequence 368 conservation on the amino acid level, PB2 1-37 -GFP failed to inhibit a panel of other influenza 369 A virus polymerases, suggesting that it might be difficult to develop an efficient broad-370 spectrum inhibitor targeting the PB1/PB2 interaction site. The resistance of most of the tested influenza A virus polymerases to inhibition by 372 PB2 1-37 -GFP could be explained by different hypotheses, two of which we would like to 373 discuss here in more detail: First, these results might indicate that the PB1/PB2 interaction via 374 the PB1 678-757 and the PB2 1-37 domains does not play a crucial role in polymerase assembly for 375 all influenza A strains. Consequently, an alternative PB1-PB2 interaction site would be 376 essential for assembly of these polymerases and the high conservation of the PB1 678-757 -377 PB2 1-37 interaction site has resulted from a different function. Second, the PB1 678-757 and the 378 PB2 1-37 protein binding domains mediate the assembly of PB2 with PB1/PA dimers, however, 379 some PB1/PA dimers shield the PB2 1-37 interaction site in the cytoplasm to prevent premature 380 formation of a trimeric polymerase complex in the cytoplasm. 381
The first hypothesis is supported by the failure of PB1 SC35M /PA SC35M dimers to bind to 382 PB2 1-37 . An alternative PB1-binding site in PB2 which has been mapped to the C-terminal 383 part of PB2 (37) might be responsible for the interaction with PB1/PA dimers of the resistant 384 influenza A virus strains. Interestingly, in the case of SC35M we even observed an increase in 385 polymerase activity in the presence of PB2 1-37 -GFP, potentially indicating a regulatory effect 386 of the PB1-PB2 1-37 interaction on polymerase activity. This is in line with the previously 387 described PB1 mutations F669A and I750D, which resulted in decreased PB1-PB2 binding, 388 but increased enzymatic activity of the polymerase (42). The proposed regulatory function 389 might be due to a PB2-NP interaction site overlapping with the PB1-PB2 interaction site at 390 PB2 1-37 . As it was described by others (37) protein as a major molecular determinant for resistance or sensitivity against inhibition by 405 PB2 1-37 -GFP, we speculate that the formation of the PB1 SC35M /PA SC35M dimer induces a 406 conformational change, which results in a "closed " conformation in which PB1 678-757 is 407 rendered inaccessible for PB2 1-37 thereby leading to resistance. The occurrence of 408 conformational changes is not unlikely since the influenza virus polymerase complex has 409 been described to be highly dynamic, adopting different conformations (5, 
